Literature DB >> 7809129

Subunit stoichiometry of staphylococcal alpha-hemolysin in crystals and on membranes: a heptameric transmembrane pore.

J E Gouaux1, O Braha, M R Hobaugh, L Song, S Cheley, C Shustak, H Bayley.   

Abstract

Elucidation of the accurate subunit stoichiometry of oligomeric membrane proteins is fraught with complexities. The interpretations of chemical cross-linking, analytical ultracentrifugation, gel filtration, and low-resolution electron microscopy studies are often ambiguous. Staphylococcal alpha-hemolysin (alpha HL), a homooligomeric toxin that forms channels in cell membranes, was believed to possess six subunits arranged around a sixfold axis of symmetry. Here, we report that analysis of x-ray diffraction data and chemical modification experiments indicate that the alpha HL oligomer is a heptamer. Self-rotation functions calculated using x-ray diffraction data from single crystals of alpha HL oligomers show a sevenfold axis of rotational symmetry. The alpha HL pore formed on rabbit erythrocyte membranes was determined to be a heptamer by electrophoretic separation of alpha HL heteromers formed from subunits with the charge of wild-type alpha HL and subunits with additional negative charge generated by targeted chemical modification of a single-cysteine mutant. These data establish the heptameric oligomerization state of the alpha HL transmembrane pore both in three-dimensional crystals and on a biological membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809129      PMCID: PMC45533          DOI: 10.1073/pnas.91.26.12828

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Oligomer formation of staphylococcal alpha-toxin analyzed by electron microscopy and image processing.

Authors:  H Hebert; A Olofsson; M Thelestam; E Skriver
Journal:  FEMS Microbiol Immunol       Date:  1992-09

2.  The three-dimensional structure of trypsin-treated Staphylococcus aureus alpha-toxin.

Authors:  A Olofsson; U Kavéus; M Thelestam; H Hebert
Journal:  J Struct Biol       Date:  1992 May-Jun       Impact factor: 2.867

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The projection structure of alpha-toxin from Staphylococcus aureus in human platelet membranes as analyzed by electron microscopy and image processing.

Authors:  A Olofsson; U Kavéus; M Thelestam; H Hebert
Journal:  J Ultrastruct Mol Struct Res       Date:  1988-08

6.  A pore-forming protein with a protease-activated trigger.

Authors:  B Walker; H Bayley
Journal:  Protein Eng       Date:  1994-01

7.  Two configurations of a channel-forming membrane protein.

Authors:  P N Unwin; P D Ennis
Journal:  Nature       Date:  1984 Feb 16-22       Impact factor: 49.962

8.  Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.

Authors:  M W Hunkapiller; E Lujan; F Ostrander; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

9.  Three-dimensional crystals of membrane proteins: bacteriorhodopsin.

Authors:  H Michel; D Oesterhelt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  The aerolysin membrane channel is formed by heptamerization of the monomer.

Authors:  H U Wilmsen; K R Leonard; W Tichelaar; J T Buckley; F Pattus
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  73 in total

1.  A functional protein pore with a "retro" transmembrane domain.

Authors:  S Cheley; O Braha; X Lu; S Conlan; H Bayley
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

Review 2.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Location of a constriction in the lumen of a transmembrane pore by targeted covalent attachment of polymer molecules.

Authors:  L Movileanu; S Cheley; S Howorka; O Braha; H Bayley
Journal:  J Gen Physiol       Date:  2001-03       Impact factor: 4.086

4.  Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore.

Authors:  George Miles; Liviu Movileanu; Hagan Bayley
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

5.  Arresting and releasing Staphylococcal alpha-hemolysin at intermediate stages of pore formation by engineered disulfide bonds.

Authors:  Toshimitsu Kawate; Eric Gouaux
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

6.  Stochastic assembly of two-component staphylococcal gamma-hemolysin into heteroheptameric transmembrane pores with alternate subunit arrangements in ratios of 3:4 and 4:3.

Authors:  Noriko Sugawara-Tomita; Toshio Tomita; Yoshiyuki Kamio
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

7.  Properties of Bacillus cereus hemolysin II: a heptameric transmembrane pore.

Authors:  George Miles; Hagan Bayley; Stephen Cheley
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

8.  Electrostatic influence on ion transport through the alphaHL channel.

Authors:  M Misakian; J J Kasianowicz
Journal:  J Membr Biol       Date:  2003-10-01       Impact factor: 1.843

9.  Highly accurate classification of Watson-Crick basepairs on termini of single DNA molecules.

Authors:  Stephen Winters-Hilt; Wenonah Vercoutere; Veronica S DeGuzman; David Deamer; Mark Akeson; David Haussler
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

10.  Crystallization and preliminary crystallographic studies of both components of the staphylococcal LukE-LukD leukotoxin.

Authors:  Romain Galy; Fabien Bergeret; Daniel Keller; Lionel Mourey; Gilles Prévost; Laurent Maveyraud
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.